ADC Therapeutics SAADCT

紐約證券 · USD
3.66
+0.09
(+2.52%)
收盤 01/10 04:59 (UTC+8)
01/10 04:59 (UTC+8)

財務數據

損益表

loading
載入中...
icon
  • 0.19
  • 0.14
  • 0.17
  • 0.18
  • 0.17
  • 0.18
  • 0.17
  • 0.23
  • 0.19
  • 0.16
icon
  • 1.53
  • -24.84
  • 15.85
  • 7.52
  • -3.56
  • 6.05
  • -8.42
  • 36.21
  • -18.21
  • -12.80
  • icon
    營業收入(億)
  • icon
    季增長率(%)
單位:美元千元
年季
2025/Q3
2025/Q2
2025/Q1
2024/Q4
2024/Q3
2024/Q2
2024/Q1
2023/Q4
2023/Q3
2023/Q2
營業收入淨額
16,427
18,839
23,033
16,910
18,464
17,410
18,053
16,790
14,493
19,283
營業成本
1,2028362,0611,3718511,2172,5102542081,132
營業毛利
15,225
18,003
20,972
15,539
17,613
16,193
15,543
16,536
14,285
18,151
營業費用
46,19462,15049,436--45,234-53,52150,19057,485
研發費用
26,80330,09028,92827,10132,50224,29525,73527,26327,08031,342
推銷及管理費用
19,01418,96920,50820,87420,67520,93923,42126,49423,35426,458
非經常性項目費用
37713,091--------
其他營業費用
---------4,881
營業利益
-30,969
-44,147
-28,464
-32,436
-35,564
-29,041
-33,613
-36,985
-35,905
-39,334
其他收入及費用
3,3951,7522,25713,3075,0626,007353---
利息費用
13,39212,99712,23011,91913,11712,67912,4967,67512,81610,309
稅前純益
-40,966
-55,392
-38,437
-31,048
-43,619
-35,713
-45,756
-34,111
-45,402
-52,653
所得稅
-1,254165-3219023416346,064-85-4,498
稅後純益
-40,966
-56,646
-38,602
-30,727
-43,969
-36,544
-46,606
-85,703
-46,726
-48,922
基本每股稅後盈餘(元)
-0.30-0.50-0.36-0.29-0.42-0.38-0.56--0.57-0.60
稀釋每股稅後盈餘(元)
-0.30-0.50-0.36-0.27-0.42-0.37-0.56--0.57-0.60
基本平均股數(千股)
136446.00113743.00107202.00105396.00104824.0095691.0082552.00-82256.0081471.00
稀釋平均股數(千股)
136446.00113743.00107202.00105396.00104824.0095691.0082552.00-82256.0081471.00
還原基本每股稅後盈餘(元)
-0.30-0.50-0.36-0.29-0.42-0.38-0.56--0.57-0.60
還原稀釋每股稅後盈餘(元)
-0.30-0.50-0.36-0.27-0.42-0.37-0.56--0.57-0.60
還原基本平均股數(千股)
136,446113,743107,202105,396104,82495,69182,552-82,25681,471
還原稀釋平均股數(千股)
136,446113,743107,202105,396104,82495,69182,552-82,25681,471
EBITDA(千元)
-19,319-34,026-18,146-11,633-22,270-15,427-25,737-30,953-33,110-42,299

大家都在看

HOT